Mosaic ImmunoEngineering Inc. (CPMV)

Mosaic ImmunoEngineering Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2018	2017
Selling, General & Admin	1.58	2.05	0.73	1.05	1.22
Research & Development	1.05	1.46	0	0	0
Other Operating Expenses	0.34	0	0	0	0
Operating Expenses	2.63	3.5	0.73	1.05	1.22
Operating Income	-2.63	-3.66	-0.73	-1.05	-1.22
Interest Income	0	0	0.03	0.03	0.02
Interest Expense	0.15	0.16	0.06	0.21	-1.17
Other Expense / Income	-0.4	-0.14	0.03	0.03	0.02
Pretax Income	-2.38	-3.68	-0.8	-1.26	-0.04
Income Tax	0	0	0	-0.05	0
Net Income	-2.38	-3.68	-0.8	-1.21	-0.05
Shares Outstanding (Basic)	7	7	1	1	1
Shares Outstanding (Diluted)	7	7	1	1	1
Shares Change	7.79%	742.14%	-	-	-
EPS (Basic)	-0.33	-0.55	-1.00	-1.52	-0.06
EPS (Diluted)	-0.33	-0.55	-1.00	-1.52	-0.06
Free Cash Flow	-0.69	-0.68	-0.76	-0.88	-1.31
Free Cash Flow Per Share	-0.10	-0.10	-0.95	-1.11	-1.65
EBITDA	-2.28	-3.5	-0.73	-1.05	-1.22
Depreciation & Amortization	0	0	0	0	0
EBIT	-	-	-0.73	-1.05	-1.22

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.